Literature DB >> 3920087

The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.

R E Bernardus, G S Jones, A A Acosta, J E Garcia, H C Liu, D L Jones, Z Rosenwaks.   

Abstract

Among the patients enrolled in the Norfolk In Vitro Fertilization Program there were 32 who had been stimulated according to the basic stimulation protocol using two ampules of human menopausal gonadotropin (hMG) daily. Because of their inadequate response, 23 of these 32 patients were stimulated subsequently with a combination of two ampules of "pure" follicle-stimulating hormone (FSH) and two ampules of hMG on cycle days 3 and 4. The remaining nine patients received four ampules of "pure" FSH only on cycle days 3 and 4. Stimulation was continued with hMG in both FSH regimens. Ten thousand units of human chorionic gonadotropin was used for final maturation. Parallel with the increase in the ratio of exogenous FSH to luteinizing hormone, an increase in oocyte recovery was observed, as well as an improvement in transfer and pregnancy rates. It was concluded that FSH enrichment had a beneficial effect in these patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920087     DOI: 10.1016/s0015-0282(16)48434-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Preliminary data on the efficacy of a new human menopausal gonadotropin (hMG) preparation containing a reduced amount of luteinizing hormone (LH) for superovulation in an in vitro fertilization (IVF) program.

Authors:  J M Antoine; J Salat-Baroux; S Alvarez; D Cornet; C Tibi; V Brieu; J Mandelbaum; M Plachot
Journal:  J Assist Reprod Genet       Date:  1992-08       Impact factor: 3.412

2.  Preovulatory serum gonadotropin levels in hMG stimulated menstrual cycles in pregnant and nonpregnant patients.

Authors:  J F van Uem; A A Acosta; J E Garcia; Z Rosenwaks
Journal:  Arch Gynecol       Date:  1987

Review 3.  Drugs used in in vitro fertilisation procedures.

Authors:  I E Messinis
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 4.  Low- versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program.

Authors:  T Levy; Z Ben-Rafael
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

5.  Ultrasonic and endocrinologic relationships in spontaneous and induced follicular phase.

Authors:  D Mango; P Scirpa; M A Spina; F Battaglia; E Tartaglia; P Manna; S Ricci; T Iacona
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.